New hope for advanced cancers: AMT-253 trial opens for patients out of options
Disease control
Recruiting now
This study tests an experimental drug called AMT-253 in people with advanced melanoma or other solid tumors that have spread or cannot be removed by surgery. Participants must have already tried at least one standard treatment without success. The goal is to see if the drug can s…
Phase: PHASE1, PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 06:51 UTC